Clinical Trial: A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer

U.S., March 22 -- ClinicalTrials.gov registry received information related to the study (NCT06887933) titled 'A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer' on March 19.

Brief Summary: The goal of this clinical trial is to learn about the safety profile of niraparib in adult female participants for the treatment of advanced or relapsed epithelial ovarian cancer.

Study Start Date: April 22

Study Type: INTERVENTIONAL

Condition: Ovarian Neoplasms

Intervention: DRUG: Niraparib

Niraparib will be administered.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: GlaxoSmithKline

Disclaimer: Curated by HT Syndication....